Omalizumab induced lichenoid drug eruption triggered by sun exposure

Abstract

Dear EditorOmalizumab is a humanized monoclonal antibody against humanimmunoglobulin E that is mainly indicated in asthma, allergic rhinitis,chronic spontaneous urticaria and is being increasingly used for otherdermatological diseases, including atopic dermatitis, mastocytosis,hyper-IgE syndrome, and bullous pemphigoid.1,2Rare cutaneous sideeffects, such as itching, skin rash, urticaria, and photosensitivity, havebeen reported to be associated with omalizumab use...